12/10/2025
🍏 Attention Patients, Providers, and Community Advocates!
Your voice matters. We’re asking for your support in protecting the 340B Cost Savings Program, a vital resource that helps ECHO continue providing accessible, affordable healthcare to our community.
Please see the link 🔗 below to voice your support! It will only take a moment, but will have a big impact.
Join our campaign to urge prescription drug manufacturers to exempt Community Health Centers (CHCs) from a rebate program that threatens patients' access to affordable medication.
The 340B Drug Pricing Program has been a vital lifeline for CHCs, enabling them to stretch scarce federal resources and provide affordable, life-saving and life-changing medications to patients with chronic illness.
HRSA’s proposed 340B Rebate Model Pilot would fundamentally disrupt this model, eliminating upfront discounts, increasing costs, straining limited cash reserves, and jeopardizing access to essential medications and primary care services.
NACHC is educating federal decision makers and drug manufacturers, but we need your voice, too.
🔗 Use the link to send letters to drug companies, HRSA, and Walgreens, urging them to protect the 340B Program and exempt CHCs from the rebate model. 👉 https://bit.ly/ExemptCHCs340BRebateModel
